Skip to main content

and
  1. Article

    Open Access

    Development of OXY111A, a novel hypoxia-modifier as a potential antitumor agent in patients with hepato-pancreato-biliary neoplasms - Protocol of a first Ib/IIa clinical trial

    Solid tumors, such as hepato-pancreato-biliary cancer, develop tumor hypoxia with tumor growth. Despite advances in surgery, a majority of these patients are in an unresectable condition. At this stage standar...

    Perparim Limani, Michael Linecker, Philipp Kron, Panagiotis Samaras in BMC Cancer (2016)